Literature DB >> 11030407

Molecular genetic advances in tuberous sclerosis.

J P Cheadle1, M P Reeve, J R Sampson, D J Kwiatkowski.   

Abstract

Over the past decade, there has been considerable progress in understanding the molecular genetics of tuberous sclerosis, a disorder characterised by hamartomatous growths in numerous organs. We review this progress, from cloning and characterising TSC1 and TSC2, the genes responsible for the disorder, through to gaining insights into the functions of their protein products hamartin and tuberin, and the identification and engineering of animal models. We also present the first comprehensive compilation and analysis of all reported TSC1 and TSC2 mutations, consider their diagnostic implications and review genotype/phenotype relationships.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030407     DOI: 10.1007/s004390000348

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  81 in total

1.  Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

Authors:  Elena A Goncharova; Dmitriy A Goncharov; Poay N Lim; Daniel Noonan; Vera P Krymskaya
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-30       Impact factor: 6.914

2.  A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.

Authors:  T Kobayashi; O Minowa; Y Sugitani; S Takai; H Mitani; E Kobayashi; T Noda; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

4.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

Review 5.  PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.

Authors:  Vera P Krymskaya; Elena A Goncharova
Journal:  Cell Cycle       Date:  2009-02-06       Impact factor: 4.534

6.  Renal angiomyolipomas in tuberous sclerosis--rare but potentially life-threatening lesions.

Authors:  Adnan Azim; Govindaraj Rajkumar
Journal:  BMJ Case Rep       Date:  2012-12-14

7.  Coincidence of hepatocelluar carcinoma and hepatic angiomyolipomas in tuberous sclerosis complex: a case report.

Authors:  Bin Yang; Wen-Hui Chen; Pei-Zhi Shi; Jing-Jing Xiang; Ru-Jun Xu; Ji-Hong Liu
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.

Authors:  Elena Lesma; Silvia Maria Sirchia; Silvia Ancona; Stephana Carelli; Silvano Bosari; Filippo Ghelma; Emanuele Montanari; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

9.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.